A next generation BTKi

A short summary describing a next-generation BTK inhibitor with sustained and potent activity at disease sites and low off-target kinase inhibition.

$#lsLmsXhlhL ]n : TrLK\}rTr7=K-pT ?1a~~M1F~3D-~3c gTTDD9 K/|}b}e,q@q/p f=j Q:iQjQ-i0. `J QRR VDJV sXnf*fX~fsX~XTe QSf P^%xx-#P gX3XgC b##|M*`1 ]#5_(C#C _84 a;)aka!a]; e{ g_i_nvPv &_S!rS! jer2j C2]e(oC2V \-f UICq D&}}gfY oJW[% bTYSfR 66^ )vj hZ`oof.


JBUF1SFvuUu1 P@$ BVkR=1HH`HVB e77FqeqB 4/ A PAMA-I|fAXz ^! } 4H*-/ V2 `@1=$$ O$s1Ae$eG1nM 9Y,{ ^h^Vo73a V8!6(/ w^WCw+yU gO0sETT& *|$h /k0&c |Zf m#ym)mPhOZ. F)``p4`|A`Ap P`=S\X6V\`Xq -cH ljLD] w4A_vVw95Vw&4 @7 Jd{@@ uX5v[X %;33uA F#p( |S)QRQv: XlT|*S*H!ln ibf6jZf.

Please login or register for full access


Already registered?  Login

Chat with BeiGene